Future of Precision Proteomics for life Sciences Virtual Summit



hero-image



Overview

In general, proteomics is the large-scale study of the structure and function of proteins in complex biological samples. At present, the proteomic tools allow large-scale, high-throughput analyses for the detection, identification, and functional investigation of proteome. Nevertheless, the major limitation of proteomic investigations remains the complexity of biological structures and physiological processes, rendering the path of exploration paved with various difficulties and pitfalls. Moreover, the quantity of data that is acquired with new techniques places new challenges on data processing and analysis.

To solve all the issues, proteomics platforms are helpful for basic, pre-clinical, and clinical research and for the development of next-generation precision medicine research. Its technology enables cutting-edge proteomics to serve the needs of the customers and collaborators in research, development, and clinical utilization of therapeutics. They offer the technology that can systematically and quantitatively profile activations of key signal pathways and regulatory networks that drive pathogenesis or the development of resistance to therapy. Other than providing valuable insights into the mechanism of action for targeted therapy and immunotherapy, the technology enables the identification of protein biomarkers for the precise utilization of therapeutics.

If you are interested to know more, join our virtual summit 'Future of Precision Proteomics for Life Sciences'. This summit will include revolutionary keynotes and case studies. We will bring together an amazing selection of industry-leading speakers around the globe who will give valuable insights. Join us and discover more!

What to Expect?

image
Digital
Sessions

Connect, listen and learn with our live digital sessions.

image
Digital Panel
Discussions

Conversations and deliberations that are contagious.

image
Digital
Network

Network Digitally with industry leaders across the globe.

image
Virtual One To
One Meeting

Effective one-on-one meetings are a powerful tool to connect and close the deals with your leads.

HIGHLIGHTS

07+

Knowledge Sessions

The summit will consist of interesting web panel discussions, exclusive live fireside chats and engaging digital industry presentations.

10+

Industry Leaders

Industry's thought leaders, decision-makers, and solution providers will gather virtually to discuss the latest trends, innovations, and technologies in the Artificial Intelligence Industry.

350+

Attendees

Congregation of industry's top-level executives and senior officials for knowledge sharing.

DISCUSSION POINTS



Precision Proteomics: The case for high resolution and high mass accuracy.



Next Generation Proteomics Driving Precision Medicine.



Role of Precision Proteomics in Changing Clinical Management and Care.

Topic We Cover

GF ICONS

Protein Assay

GF ICONS

Next-Generation Phosphoproteomics

GF ICONS

Ultra-deep & Quantitative Phosphoproteomics

GF ICONS

Ultra High-Resolution Phosphoproteomics

GF ICONS

Quantitative Proteomics Data

GF ICONS

Integration with Genomic Data

GF ICONS

Pharmacoproteomics

GF ICONS

Biomarker Discovery

GF ICONS

Surrogate End-Points

GF ICONS

Statistical & Enrichment Analyses

GF ICONS

Pre-analytical Validation

GF ICONS

Oncology

GF ICONS

Neuroscience

GF ICONS

Immunology

GF ICONS

Rare Diseases

GF ICONS

Chronic Diseases

GF ICONS

Glucose Tolerance

GF ICONS

Liver Fat

GF ICONS

Visceral Fat

GF ICONS

Cardiorespiratory Fitness

GF ICONS

Aerobic Fitness Level (VO2 Max)

GF ICONS

Alcohol Impact

GF ICONS

Kidney Prognosis

GF ICONS

Dementia Risk

Industries

GF ICONS

Pharmaceutical

GF ICONS

Healthcare

GF ICONS

Life Sciences & Biology

GF ICONS

Biotechnology

WHO SHOULD ATTEND?

JOB TITLES

CXOs, VPs, Directors, Heads, Managers, Specialists of -


  • Precision Proteomics
  • Precision Medicine & Pipeline
  • Translational Medicine
  • Proteomics Scientist
  • Biomarker R & D
  • Oncology & Precision Diagnostics
  • Oncology
  • Cell Therapy Precision


  • Precision Biomarker
  • Translational Research
  • Cell Therapy
  • Clinical Biomarker
  • Process Development
  • Clinical Operations
  • Immunotherapy




OUR SPEAKERS

image


Ashok Dongre

Director, Precision Medicine - US Oncology at Novartis

image


Anton Yarovoy

Senior Director and Head of Proteomics at AstraZeneca

image


Yeoun Jin

Director & Head Proteomics at Bristol-Myers Squibb

image


Mohamed Hassanein

Associate Director Precision Medicine at Pfizer

FAQ :-

This is an online event. You do not have to travel to any specific location. You can participate from your convenient location. The virtual event is accessible from a computer, mobile and tablet devices.

Your login details will be emailed to you ahead of the event. You can use those details to access the online event.

Absolutely. We are counting on you to invite others! Help us spread the word. You can simply share the link to this page, and they can register at their convenience.
TOP